The University of Chicago Header Logo

Connection

Russell Szmulewitz to Glutamate Carboxypeptidase II

Back to Details
This is a "connection" page, showing publications Russell Szmulewitz has written about Glutamate Carboxypeptidase II.
Russell Szmulewitz
Connection Strength
0.487
Glutamate Carboxypeptidase II
  1. [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial. Lancet. 2026 Aug 29; 408(10557):793-807.
    View in: PubMed
    Score: 0.246
  2. 131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study. Clin Cancer Res. 2026 May 15; 32(10):1973-1982.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.